This topic contains a solution. Click here to go to the answer

Author Question: What is the rationale for administering levodopa instead of dopamine for treatment of Parkinson's ... (Read 77 times)

pane00

  • Hero Member
  • *****
  • Posts: 579
What is the rationale for administering levodopa instead of dopamine for treatment of Parkinson's disease?
 
  a. Dopamine does not cross the bloodbrain barrier when administered orally.
  b. Levodopa is much less expensive.
  c. The half-life of dopamine is too short.
  d. Dopamine has too many reactions with other medications.

Question 2

When a patient taking a monoamine oxidase B inhibitor receives his dietary tray, the nurse knows to remove the
 
  a. cheese.
  b. eggs.
  c. bread.
  d. coffee.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cam1229

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

ANS: A
When administered orally, dopamine does not enter the brain. Levodopa does cross into the brain and is metabolized into dopamine. Dopamine is not available as an oral medication. The half-life of levodopa is approximately 50 minutes; the half-life of dopamine is approximately 4 days. Dopamine does not react with medications.

Answer to Question 2

ANS: A
Patients taking monoamine oxidase B inhibitors should avoid food and beverages with a high tyramine content, such as cheeses. Eggs, bread, and coffee do not have a high tyramine content.



pane00

  • Hero Member
  • *****
  • Posts: 579
Both answers were spot on, thank you once again




 

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

For a complete list of videos, visit our video library